ADMS - Adamas Knife Continues To Fall As Value Continues To Rise
Adamas Pharmaceuticals, Inc. (ADMS) has had a volatile 2018 experiencing all-time highs and lows. I recently published an article on Adamas reviewing the results of the company's 3rd quarter earnings report and subsequent demolition of the share price. In that article, I categorized ADMS as a falling knife and recommended investors to wait for positive news or for the stock's technicals to change before adding to or initiating a position. Although I still maintain that strategy, recent overall market performance has dragged the share price to an all-time low, and I am adding